Nanobiotix
NBTX
24.62
-0.61
-2.42%
Nanobiotix
US · NBTX
#3096 by market cap
Listed 2020
24.62
-0.61
-2.42%
Live - 5344 symbols - heartbeat 190s ago
· 2026-10-08 05:24
Pre-market
23.72
-3.65%
After-hours
24.62
0.00%
Overnight
24.06
-2.27%
- Market cap
- 1.25B
- P/E (TTM)i
- -20.18
- P/Bi
- -33.54
- EPSi
- -0.56
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on NBTX?
Anonymous reader poll. Unscientific, not investment advice.
About Nanobiotix
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
- Founded
- 2003
- CEO
- Dr. Laurent Levy, PhD
- Employees
- 97
- Headquarters
- Paris, Ile-de-France, France
- Fiscal year end
- 12-31
- Website
- nanobiotix.com
Company profile
- Exchange
- US
- Symbol
- NBTX
- Market-cap rank
- #3096
- Listing date
- 2020-12-11
- Market cap
- 1.25B
- Float cap
- 868.15M
- Shares out
- 50.92M
- Float shares
- 35.26M
Sectors & themes
Biotechnology
Stocks tradable only on moomoo
Quote time 2026-10-08 05:24:16 · For reference only, not investment advice and not tailored to your situation.